Identification of NURR1 as a mediator of MIF signaling during chronic arthritis: Effects on glucocorticoid-induced MKP1

American Journal of Pathology

Volumn 177, Issue 5, 2010, Pages 2366-2378

  Ralph, Jennifer A ^a,d   Ahmed, Afsar U ^a   Santos, Leilani L ^a   Clark, Andrew R ^b   McMorrow, Jason ^c   Murphy, Evelyn P ^c   Morand, Eric F ^a  

^a MONASH UNIVERSITY   (Australia)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

^d SCIENCE FOUNDATION IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; GLUCOCORTICOID; MACROPHAGE MIGRATION INHIBITION FACTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; NUCLEAR RECEPTOR RELATED FACTOR 1; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC ARTHRITIS; CHRONIC INFLAMMATION; CONTROLLED STUDY; FIBROBLAST; GENE; MKP1 GENE; MOUSE; NERVE GROWTH FACTOR INDUCED CLONE B RESPONSE ELEMENT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYNOVIOCYTE; SYNOVIUM; TRANSACTIVATION;

EID: 78149317984     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.091204     Document Type: Article

References (73)

1. Tak PP, Bresnihan B: The pathogenesis and prevention of joint damage in rheumatoid arthritis: advances from synovial biopsy and tissue analysis. Arthritis Rheum 2000, 43:2619-2633
2. Ben-Av P, Crofford LJ, Wilder RL, Hla T: Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis. FEBS Lett 1995, 372:83-87
3. Leech M, Metz C, Hall P, Hutchinson P, Gianis K, Smith M, Weedon H, Holdsworth SR, Bucala R, Morand EF: Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids. Arthritis Rheum 1999, 42:1601-1608
4. Schett G, Tohidast-Akrad M, Smolen JS, Schmid BJ, Steiner CW, Bitzan P, Zenz P, Redlich K, Xu Q, Steiner G: Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis. Arthritis Rheum 2000, 43:2501-2512
5. Chrousos GP: The hypothalamic-pituitary-adrenal axis and immunemediated inflammation. N Engl J Med 1995, 332:1351-1362
6. Leech M, Metz C, Bucala R, Morand EF: Regulation of macrophage migration inhibitory factor by endogenous glucocorticoids in rat adjuvant-induced arthritis. Arthritis Rheum 2000, 43:827-833
7. Leech M, Lacey D, Xue JR, Santos L, Hutchinson P, Wolvetang E, David JR, Bucala R, Morand EF: Regulation of p53 by macrophage migration inhibitory factor in inflammatory arthritis. Arthritis Rheum 2003, 48:1881-1889 (Pubitemid 36828683)
8. Leech M, Metz C, Santos L, Peng T, Holdsworth SR, Bucala R, Morand EF: Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis. Arthritis Rheum 1998, 41:910-917 (Pubitemid 28225792)
9. Santos LL, Lacey D, Yang Y, Leech M, Morand EF: Activation of synovial cell p38 MAP kinase by macrophage migration inhibitory factor. J Rheumatol 2004, 31:1038-1043
10. Santos LL, Dacumos A, Yamana J, Sharma L, Morand EF: Reduced arthritis in MIF deficient mice is associated with reduced T cell activation: down-regulation of ERK MAP kinase phosphorylation. Clin Exp Immunol 2008, 152:372-380
11. Sampey AV, Hall PH, Mitchell RA, Metz CN, Morand EF: Regulation of synoviocyte phospholipase A2 and cyclooxygenase 2 by macrophage migration inhibitory factor. Arthritis Rheum 2001, 44:1273-1280
12. Onodera S, Ohshima S, Tohyama H, Yasuda K, Nishihira J, Iwakura Y, Matsuda I, Minami A, Koyama Y: A novel DNA vaccine targeting macrophage migration inhibitory factor protects joints from inflammation and destruction in murine models of arthritis. Arthritis Rheum 2007, 56:521-530
13. Pakozdi A, Amin MA, Haas CS, Martinez RJ, Haines GK, 3rd, Santos LL, Morand EF, David JR, Koch AE: Macrophage migration inhibitory factor: a mediator of matrix metalloproteinase-2 production in rheumatoid arthritis. Arthritis Res Ther 2006, 8:R132
14. Piette C, Deprez M, Roger T, Noel A, Foidart JM, Munaut C: The dexamethasone-induced inhibition of proliferation, migration and invasion in glioma cell lines is antagonized by macrophage migration inhibitory factor (MIF) and can be enhanced by specific MIF inhibitors. J Biol Chem 2009, 284:32483-32492
15. Aeberli D, Yang Y, Mansell A, Santos L, Leech M, Morand EF: Endogenous macrophage migration inhibitory factor modulates glucocorticoid sensitivity in macrophages via effects on MAP kinase phosphatase-1 and p38 MAP kinase. FEBS Lett 2006, 580:974-981
16. Roger T, Chanson AL, Knaup-Reymond M, Calandra T: Macrophage migration inhibitory factor promotes innate immune responses by suppressing glucocorticoid-induced expression of mitogen-activated protein kinase phosphatase-1. Eur J Immunol 2005, 35:3405-3413
17. Liu Y, Shepherd EG, Nelin LD: MAPK phosphatases-regulating the immune response. Nat Rev Immunol 2007, 7:202-212
18. Franklin CC, Kraft AS: Conditional expression of the mitogen-activated protein kinase (MAPK) phosphatase MKP-1 preferentially inhibits p38 MAPK and stress-activated protein kinase in U937 cells. J Biol Chem 1997, 272:16917-16923
19. Lai LP, Mitchell J: Parathyroid hormone inhibits phosphorylation of mitogen-activated protein kinase (MAPK) ERK1/2 through inhibition of c-Raf and activation of MKP-1 in osteoblastic cells. Cell Biochem Funct 2009, 27:269-275
20. Lasa M, Abraham SM, Boucheron C, Saklatvala J, Clark AR: Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38. Mol Cell Biol 2002, 22:7802-7811
21. Brondello JM, Brunet A, Pouyssegur J, McKenzie FR: The dual specificity mitogen-activated protein kinase phosphatase-1 and -2 are induced by the p42/p44MAPK cascade. J Biol Chem 1997, 272: 1368-1376
22. Toh ML, Yang Y, Leech M, Santos L, Morand EF: Expression of mitogen-activated protein kinase phosphatase 1, a negative regulator of the mitogen-activated protein kinases, in rheumatoid arthritis: upregulation by interleukin-1beta and glucocorticoids. Arthritis Rheum 2004, 50:3118-3128
23. Sanchez-Tillo E, Comalada M, Xaus J, Farrera C, Valledor AF, Caelles C, Lloberas J, Celada A: JNK1 is required for the induction of Mkp1 expression in macrophages during proliferation and lipopolysaccharide-dependent activation. J Biol Chem 2007, 282:12566-12573
24. Chi H, Barry SP, Roth RJ, Wu JJ, Jones EA, Bennett AM, Flavell RA: Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. Proc Natl Acad Sci USA 2006, 103:2274-2279
25. Maier JV, Brema S, Tuckermann J, Herzer U, Klein M, Stassen M, Moorthy A, Cato AC: Dual specificity phosphatase 1 knockout mice show enhanced susceptibility to anaphylaxis but are sensitive to glucocorticoids. Mol Endocrinol 2007, 21:2663-2671
26. Salojin KV, Owusu IB, Millerchip KA, Potter M, Platt KA, Oravecz T: Essential role of MAPK phosphatase-1 in the negative control of innate immune responses. J Immunol 2006, 176:1899-1907
27. Wu JJ, Roth RJ, Anderson EJ, Hong EG, Lee MK, Choi CS, Neufer PD, Shulman GI, Kim JK, Bennett AM: Mice lacking MAP kinase phosphatase-1 have enhanced MAP kinase activity and resistance to diet-induced obesity. Cell Metab 2006, 4:61-73
28. Wang X, Zhao Q, Matta R, Meng X, Liu X, Liu CG, Nelin LD, Liu Y: Inducible nitric oxide synthase expression is regulated by MAP kinase phosphatase-1. J Biol Chem 2009, 284:27123-27134
29. Zhao Q, Wang X, Nelin LD, Yao Y, Matta R, Manson ME, Baliga RS, Meng X, Smith CV, Bauer JA, Chang CH, Liu Y: MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock. J Exp Med 2006, 203:131-140
30. Zhao Q, Shepherd EG, Manson ME, Nelin LD, Sorokin A, Liu Y: The role of mitogen-activated protein kinase phosphatase-1 in the response of alveolar macrophages to lipopolysaccharide: attenuation of proinflammatory cytokine biosynthesis via feedback control of p38. J Biol Chem 2005, 280:8101-8108
31. Horsch K, de Wet H, Schuurmans MM, Allie-Reid F, Cato AC, Cunningham J, Burrin JM, Hough FS, Hulley PA: Mkp-1/Dusp1 mediates glucocorticoid inhibition of osteoblast proliferation. Mol Endocrinol 2007, 21:2929-2940
32. Abraham SM, Lawrence T, Kleiman A, Warden P, Medghalchi M, Tuckermann J, Saklatvala J, Clark AR: Anti-inflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1. J Exp Med 2006, 203:1883-1889
33. Kassel O, Sancono A, Kratzschmar J, Kreft B, Stassen M, Cato AC: Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J 2001, 20:7108-7116
34. Murphy EP, Conneely OM: Neuroendocrine regulation of the hypothalamic pituitary adrenal axis by the nurr1/nur77 subfamily of nuclear receptors. Mol Endocrinol 1997, 11:39-47
35. Zetterstrom RH, Solomin L, Jansson L, Hoffer BJ, Olson L, Perlmann T: Dopamine neuron agenesis in Nurr1-deficient mice. Science 1997, 276:248-250
36. Saijo K, Winner B, Carson CT, Collier JG, Boyer L, Rosenfeld MG, Gage FH, Glass CK: A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell 2009, 137:47-59
37. Chu Y, Le W, Kompoliti K, Jankovic J, Mufson EJ, Kordower JH: Nurr1 in Parkinson's disease and related disorders. J Comp Neurol 2006, 494:495-514
38. Mix KS, Attur MG, Al-Mussawir H, Abramson SB, Brinckerhoff CE, Murphy EP: Transcriptional repression of matrix metalloproteinase gene expression by the orphan nuclear receptor NURR1 in cartilage. J Biol Chem 2007, 282:9492-9504
39. Murphy EP, McEvoy A, Conneely OM, Bresnihan B, FitzGerald O: Involvement of the nuclear orphan receptor NURR1 in the regulation of corticotropin- releasing hormone expression and actions in human inflammatory arthritis. Arthritis Rheum 2001, 44:782-793
40. Arkenbout EK, de Waard V, van Bragt M, van Achterberg TA, Grimbergen JM, Pichon B, Pannekoek H, de Vries CJ: Protective function of transcription factor TR3 orphan receptor in atherogenesis: decreased lesion formation in carotid artery ligation model in TR3 transgenic mice. Circulation 2002, 106:1530-1535
41. Aherne CM, McMorrow J, Kane D, Fitzgerald O, Mix KS, Murphy EP: Identification of NR4A2 as a transcriptional activator of IL-8 expression in human inflammatory arthritis. Mol Immunol 2009, 46: 3345-3357
42. Holla VR, Mann JR, Shi Q, DuBois RN: Prostaglandin E2 regulates the nuclear receptor NR4A2 in colorectal cancer. J Biol Chem 2006, 281:2676-2682
43. Pei L, Castrillo A, Chen M, Hoffmann A, Tontonoz P: Induction of NR4A orphan nuclear receptor expression in macrophages in response to inflammatory stimuli. J Biol Chem 2005, 280:29256-29262
44. Ralph JA, McEvoy AN, Kane D, Bresnihan B, FitzGerald O, Murphy EP: Modulation of orphan nuclear receptor NURR1 expression by methotrexate in human inflammatory joint disease involves adenosine A2A receptor-mediated responses. J Immunol 2005, 175:555-565
45. Bonta PI, van Tiel CM, Vos M, Pols TW, van Thienen JV, Ferreira V, Arkenbout EK, Seppen J, Spek CA, van der Poll T, Pannekoek H, de Vries CJ: Nuclear receptors Nur77, Nurr1, and NOR-1 expressed in atherosclerotic lesion macrophages reduce lipid loading and inflammatory responses. Arterioscler Thromb Vasc Biol 2006, 26:2288-2294
46. McEvoy AN, Murphy EA, Ponnio T, Conneely OM, Bresnihan B, FitzGerald O, Murphy EP: Activation of nuclear orphan receptor NURR1 transcription by NF-kappa B and cyclic adenosine 5′-monophosphate response element-binding protein in rheumatoid arthritis synovial tissue. J Immunol 2002, 168:2979-2987
47. Maxwell MA, Muscat GE: The NR4A subgroup: immediate early response genes with pleiotropic physiological roles. Nucl Recept Signal 2006, 4:e002
48. Nordzell M, Aarnisalo P, Benoit G, Castro DS, Perlmann T: Defining an N-terminal activation domain of the orphan nuclear receptor Nurr1. Biochem Biophys Res Commun 2004, 313:205-211 (Pubitemid 37524044)
49. Galleguillos D, Vecchiola A, Fuentealba JA, Ojeda V, Alvarez K, Gomez A, Andres ME: PIASgamma represses the transcriptional activation induced by the nuclear receptor Nurr1. J Biol Chem 2004, 279:2005-2011
50. Carpentier R, Sacchetti P, Segard P, Staels B, Lefebvre P: The glucocorticoid receptor is a co-regulator of the orphan nuclear receptor Nurr1. J Neurochem 2008, 104:777-789
51. Lammi J, Huppunen J, Aarnisalo P: Regulation of the osteopontin gene by the orphan nuclear receptor NURR1 in osteoblasts. Mol Endocrinol 2004, 18:1546-1557 (Pubitemid 38696932)
52. Pirih FQ, Tang A, Ozkurt IC, Nervina JM, Tetradis S: Nuclear orphan receptor Nurr1 directly transactivates the osteocalcin gene in osteoblasts. J Biol Chem 2004, 279:53167-53174
53. Tetradis S, Bezouglaia O, Tsingotjidou A: Parathyroid hormone induces expression of the nuclear orphan receptor Nurr1 in bone cells. Endocrinology 2001, 142:663-670 (Pubitemid 32222415)
54. Engelbrecht Y, de Wet H, Horsch K, Langeveldt CR, Hough FS, Hulley PA: Glucocorticoids induce rapid up-regulation of mitogen-activated protein kinase phosphatase-1 and dephosphorylation of extracellular signal-regulated kinase and impair proliferation in human and mouse osteoblast cell lines. Endocrinology 2003, 144:412-422
55. Wu Y, Ghosh S, Nishi Y, Yanase T, Nawata H, Hu Y: The orphan nuclear receptors NURR1 and NGFI-B modulate aromatase gene expression in ovarian granulosa cells: a possible mechanism for repression of aromatase expression upon luteinizing hormone surge. Endocrinology 2005, 146:237-246
56. McEvoy AN, Bresnihan B, FitzGerald O, Murphy EP: Cyclooxygenase 2-derived prostaglandin E2 production by corticotropin-releasing hormone contributes to the activated cAMP response element binding protein content in rheumatoid arthritis synovial tissue. Arthritis Rheum 2004, 50:1132-1145
57. Krause A, Holtmann H, Eickemeier S, Winzen R, Szamel M, Resch K, Saklatvala J, Kracht M: Stress-activated protein kinase/Jun N-terminal kinase is required for interleukin (IL)-1-induced IL-6 and IL-8 gene expression in the human epidermal carcinoma cell line KB. J Biol Chem 1998, 273:23681-23689
58. Jackson JR, Bolognese B, Hillegass L, Kassis S, Adams J, Griswold DE, Winkler JD: Pharmacological effects of SB 220025, a selective inhibitor of P38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models. J Pharmacol Exp Ther 1998, 284:687-692
59. Han Z, Chang L, Yamanishi Y, Karin M, Firestein GS: Joint damage and inflammation in c-Jun N-terminal kinase 2 knockout mice with passive murine collagen-induced arthritis. Arthritis Rheum 2002, 46:818-823
60. Mengshol JA, Vincenti MP, Coon CI, Barchowsky A, Brinckerhoff CE: Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB: differential regulation of collagenase 1 and collagenase 3. Arthritis Rheum 2000, 43:801-811
61. Pei L, Castrillo A, Tontonoz P: Regulation of macrophage inflammatory gene expression by the orphan nuclear receptor Nur77. Mol Endocrinol 2006, 20:786-794
62. Martinez-Gonzalez J, Rius J, Castello A, Cases-Langhoff C, Badimon L: Neuron-derived orphan receptor-1 (NOR-1) modulates vascular smooth muscle cell proliferation. Circ Res 2003, 92:96-103
63. Onodera S, Nishihira J, Koyama Y, Majima T, Aoki Y, Ichiyama H, Ishibashi T, Minami A: Macrophage migration inhibitory factor upregulates the expression of interleukin-8 messenger RNA in synovial fibroblasts of rheumatoid arthritis patients: common transcriptional regulatory mechanism between interleukin-8 and interleukin-1beta. Arthritis Rheum 2004, 50:1437-1447
64. Doi M, Cho S, Yujnovsky I, Hirayama J, Cermakian N, Cato AC, Sassone-Corsi P: Light-inducible and clock-controlled expression of MAP kinase phosphatase 1 in mouse central pacemaker neurons. J Biol Rhythms 2007, 22:127-139
65. Furst R, Zahler S, Vollmar AM: Dexamethasone-induced expression of endothelial mitogen-activated protein kinase phosphatase-1 involves activation of the transcription factors activator protein-1 and 3′,5′-cyclic adenosine 5′-monophosphate response element-binding protein and the generation of reactive oxygen species. Endocrinology 2008, 149:3635-3642
66. Casals-Casas C, Alvarez E, Serra M, de la Torre C, Farrera C, Sanchez-Tillo E, Caelles C, Lloberas J, Celada A: CREB and AP-1 activation regulates MKP-1 induction by LPS or M-CSF and their kinetics correlate with macrophage activation versus proliferation. Eur J Immunol 2009, 39:1902-1913
67. Johansson-Haque K, Palanichamy E, Okret S: Stimulation of MAPK-phosphatase 1 gene expression by glucocorticoids occurs through a tethering mechanism involving C/EBP. J Mol Endocrinol 2008, 41:239-249
68. Tchen CR, Martins JR, Paktiawal N, Perelli R, Saklatvala J, Clark AR: Glucocorticoid regulation of mouse and human dual specificity phosphatase 1 (DUSP1) genes: unusual cis-acting elements and unexpected evolutionary divergence. J Biol Chem 2009, 285:2642-2652
69. Yang H, Wu GS: p53 Transactivates the phosphatase MKP1 through both intronic and exonic p53 responsive elements. Cancer Biol Ther 2004, 3:1277-1282
70. Pirih FQ, Aghaloo TL, Bezouglaia O, Nervina JM, Tetradis S: Parathyroid hormone induces the NR4A family of nuclear orphan receptors in vivo. Biochem Biophys Res Commun 2005, 332:494-503
71. Zierold C, Nehring JA, DeLuca HF: Nuclear receptor 4A2 and C/EBPbeta regulate the parathyroid hormone-mediated transcriptional regulation of the 25-hydroxyvitamin D3-1alpha-hydroxylase. Arch Biochem Biophys 2007, 460:233-239
72. Nervina JM, Magyar CE, Pirih FQ, Tetradis S: PGC-1alpha is induced by parathyroid hormone and coactivates Nurr1-mediated promoter activity in osteoblasts. Bone 2006, 39:1018-1025
73. Carlson J, Cui W, Zhang Q, Xu X, Mercan F, Bennett AM, Vignery A: Role of MKP-1 in osteoclasts and bone homeostasis. Am J Pathol 2009, 175:1564-1573